Jan 28 (Reuters) - Ionis Pharmaceuticals Inc:

* IONIS PHARMACEUTICALS - ANNOUNCED PARTNER ROCHE, ALSO KNOWN AS GENENTECH IN U.S., ENROLLED FIRST PATIENT IN STUDY OF RG6042 FOR HUNTINGTON’S DISEASE

* IONIS PHARMACEUTICALS INC - EARNED $35 MILLION MILESTONE PAYMENT FOR INITIATION OF STUDY OF RG6042 Source text for Eikon: Further company coverage: